CONMED Corp filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-06-17. Between them they name 3 people. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: John E. Gallagher, Chief Financial Officer
On June 17, 2026, CONMED Corporation (the "Company") announced that John E. Gallagher has been appointed to serve as the Company's Executive Vice President, Chief Financial Officer beginning July 15, 2026 (the "Effective Date").
Appointed: Celine Martin, Director, effective 2026-07-01
Appointment of Non-Employee Directors On May 19, 2026, the Board of Directors (the "Board") of CONMED Corporation (the "Company") increased the size of the Board to nine directors and appointed Celine Martin and Jeff Mirviss as directors, each effective July 1, 2026.
Appointed: Celine Martin
Ms. Martin was appointed to the Audit Committee and the Strategy Committee.
Appointed: Kimberly Lockwood, Controller, effective 2026-06-01
On May 19, 2026, the Board appointed Kimberly Lockwood as Interim Corporate Controller and Interim Principal Accounting Officer of the Company effective June 1, 2026.
Find people with the same kind of experience as the Chief Financial Officer at CONMED Corp, with the record behind each one.
Find candidates like Chief Financial Officer at CONMED CorpNew leaders review vendors and budgets in their first months. Get an alert the next time CONMED Corp is in the news or changes leadership.
Get an alert when CONMED Corp changes leadershipTools for this story
Each opens in a new tab, filled in for CONMED Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.